What is the market doing?
What the tape says about TRVI
Trevi Therapeutics, Inc. is +146% over the past year while the S&P 500 is +23%: 123 points ahead of the market.
+146%
1-year return · S&P 500 +23%
- vs 200-day average
- +34%
vs 200-day average · a clear uptrend
- RSI (14)
- 41
RSI (14) · neutral
- Below its 52-week high
- −6.0%
Below its 52-week high
Details›
- Last close2026-08-26
- $17.93
- 1 monthS&P 500 +3.7%
- +4.4%
- 1 yearS&P 500 +23%
- +146%
- 5 yearsS&P 500 +87%
- +806%
- vs 50-day average$16.87
- +6.3%
- 52-week high
- $19.07
- 52-week low
- $7.01
- Annualised volatility
- 75%
| Year | Return |
|---|---|
| 2026 (year to date) | +43% |
| 2025 | +204% |
| 2024 | +207% |
| 2023 | −31% |
| 2022 | +147% |
| 2021 | −68% |
| 2020 | −35% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 4 of 7 | +6.2% |
| Feb | 7 | 6 of 7 | +19% |
| Mar | 7 | 4 of 7 | +34% |
| Apr | 7 | 4 of 7 | +13% |
| May | 7 | 1 of 7 | −11% |
| Jun | 8 | 6 of 8 | +22% |
| Jul | 8 | 4 of 8 | −0.86% |
| Aug | 8 | 1 of 8 | −7.2% |
| Sep | 7 | 2 of 7 | −6.6% |
| Oct | 7 | 2 of 7 | −6.4% |
| Nov | 7 | 2 of 7 | −4.6% |
| Dec | 7 | 4 of 7 | +3.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.